Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Cash & Current Investments: 2022-2024

Historic Cash & Current Investments for Maravai Lifesciences Holdings (MRVI) over the last 3 years, with Dec 2024 value amounting to $323.8 million.

  • Maravai Lifesciences Holdings' Cash & Current Investments fell 57.87% to $243.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year decrease of 51.09%. This contributed to the annual value of $323.8 million for FY2024, which is 43.69% down from last year.
  • Per Maravai Lifesciences Holdings' latest filing, its Cash & Current Investments stood at $323.8 million for FY2024, which was down 43.69% from $575.0 million recorded in FY2023.
  • In the past 5 years, Maravai Lifesciences Holdings' Cash & Current Investments registered a high of $632.1 million during FY2022, and its lowest value of $323.8 million during FY2024.
  • Over the past 3 years, Maravai Lifesciences Holdings' median Cash & Current Investments value was $575.0 million (recorded in 2023), while the average stood at $510.3 million.
  • Data for Maravai Lifesciences Holdings' Cash & Current Investments shows a maximum YoY plummeted of 43.69% (in 2024) over the last 5 years.
  • Over the past 3 years, Maravai Lifesciences Holdings' Cash & Current Investments (Yearly) stood at $632.1 million in 2022, then declined by 9.04% to $575.0 million in 2023, then plummeted by 43.69% to $323.8 million in 2024.